Prime Medicine, Inc.

Contributing Author

Recent Articles by Prime Medicine, Inc.

Dec-07	Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease PRME GlobeNewswire
Nov-25	Prime Medicine to Present at 8th Annual Evercore Healthcare Conference PRME GlobeNewswire
Nov-11	Prime Medicine to Present at Jefferies Global Healthcare Conference PRME GlobeNewswire
Nov-07	CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates PRME GlobeNewswire
Nov-07	Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates PRME GlobeNewswire
Nov-03	Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer PRME GlobeNewswire
Oct-30	Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy PRME GlobeNewswire
Oct-07	Prime Medicine to Participate in Upcoming Investor Conferences PRME GlobeNewswire
Aug-26	Prime Medicine to Participate in Upcoming Investor Conferences PRME GlobeNewswire
Aug-07	Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates PRME GlobeNewswire
Aug-01	Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares PRME GlobeNewswire
Jul-30	Prime Medicine Announces Pricing of Public Offering PRME GlobeNewswire
Jul-30	Prime Medicine Announces Proposed Public Offering of Common Stock PRME GlobeNewswire
Jul-16	Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis PRME GlobeNewswire
May-29	Prime Medicine to Participate in Upcoming Investor Conferences PRME GlobeNewswire
May-19	Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition PRME GlobeNewswire
May-19	Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease PRME GlobeNewswire
May-08	Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates PRME GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.